Harmony Biosciences Holdings, Inc. (HRMY) NASDAQ

35.99

-0.31(-0.85%)

Updated at September 05 04:00PM

Currency In USD

Valuation

Market Cap1.96B
Enterprise Value1.68B
P/E Ratio11.43
PEG Ratio0.62
Price/Sales Ratio2.68
Price/Book Ratio2.68
Enterprise/Revenue2.2
Enterprise/EBITDA6.4

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.23
Operating Margin0.29

Management Effectiveness

Return On Assets0.16
Return On Equity0.26

Income Statement

Revenue714.73M
Revenue/Share13.44
Gross Profit557.92M
EBITDA233.41M
Net Income145.49M
Diluted EPS2.51

Balance Sheet

Total Cash565.27M
Total Cash/Share9.84
Total Debt172.1M
Total Debt/Equity0.22
Current Ratio3.84
Book Value Per Share13.45

Price History

52-Week Change-2.44
52-Week High41.61
52-Week Low26.47
Moving Average 50 Days35.37
Moving Average 200 Days34.33

Statistics

Average Volume600,983
Shares Outstanding57.53M
% Held by Institutions85.44

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A